| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.021 | 0.7 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.043 | 0.5 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.044 | 0.4 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.05 | 0.3 |